0001484612-22-000006.txt : 20220105 0001484612-22-000006.hdr.sgml : 20220105 20220105165918 ACCESSION NUMBER: 0001484612-22-000006 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220103 FILED AS OF DATE: 20220105 DATE AS OF CHANGE: 20220105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vazquez Martin CENTRAL INDEX KEY: 0001823380 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39513 FILM NUMBER: 22512009 MAIL ADDRESS: STREET 1: 3052 ORCHARD DR. CITY: SAN JOSE STATE: CA ZIP: 95134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Outset Medical, Inc. CENTRAL INDEX KEY: 0001484612 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 200514392 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 3052 ORCHARD DRIVE CITY: SAN JOSE STATE: CA ZIP: 95134 BUSINESS PHONE: 669-231-8200 MAIL ADDRESS: STREET 1: 3052 ORCHARD DRIVE CITY: SAN JOSE STATE: CA ZIP: 95134 FORMER COMPANY: FORMER CONFORMED NAME: Home Dialysis Plus, Ltd. DATE OF NAME CHANGE: 20100219 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2022-01-03 0 0001484612 Outset Medical, Inc. OM 0001823380 Vazquez Martin 3052 ORCHARD DRIVE SAN JOSE CA 95134 0 1 0 0 Chief Operating Officer Common Stock 2022-01-03 4 M 0 3208 3.88 A 12463 D Common Stock 2022-01-03 4 S 0 3208 47.0394 D 9255 D Common Stock 2022-01-03 4 M 0 1378 4.11 A 10633 D Common Stock 2022-01-03 4 S 0 1378 47.0394 D 9255 D Common Stock 2022-01-03 4 M 0 414 3.88 A 9669 D Common Stock 2022-01-03 4 S 0 414 47.0394 D 9255 D Common Stock 2022-01-03 4 M 0 5000 4.11 A 14255 D Common Stock 2022-01-03 4 S 0 5000 47.0459 D 9255 D Common Stock 2022-01-03 4 M 0 6000 4.11 A 15255 D Common Stock 2022-01-03 4 S 0 6000 47.0669 D 9255 D Non-Qualified Stock Option (right to buy) 3.88 2022-01-03 4 M 0 414 0.0 D 2027-12-19 Common Stock 414 19075 D Non-Qualified Stock Option (right to buy) 4.11 2022-01-03 4 M 0 1378 0.0 D 2028-11-03 Common Stock 1378 25204 D Non-Qualified Stock Option (right to buy) 4.11 2022-01-03 4 M 0 5000 0.0 D 2028-11-03 Common Stock 5000 20204 D Non-Qualified Stock Option (right to buy) 4.11 2022-01-03 4 M 0 6000 0.0 D 2028-11-03 Common Stock 6000 14204 D Performance Options (right to buy) 3.88 2022-01-03 4 M 0 3208 0.0 D 2027-12-19 Common Stock 3208 137675 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 400 shares; $46.00-$46.99 - 854 shares; $47.00-$47.99 - 3,746 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 400 shares; $46.00-$46.99 - 854 shares; $47.00-$47.99 - 3,546 shares; $48.00 - $48.99 - 200 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 430 shares; $46.00-$46.99 - 964 shares; $47.00-$47.99 - 4,430 shares; $48.00 - $48.99 - 176 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This option vests 25% on October 9, 2018 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. This option vests in 48 equal monthly installments beginning on December 3, 2018, subject to the reporting person's continued employment through the applicable vesting date. This option vests if and to the extent that (1) the sum of (A) the 30-day closing price trading average of one share and (b) the aggregate amount of cash distributed with respect to one share (the "Aggregate Cash Distributions") is equal to or greater than $28.52 (reduced to $20.46) on any day following the expiration of the post-offering lock-up period or (11) the sum of (x) the value of all consideration that is distributable with respect to one Share in connection with a "Corporate Event" (as defined in the Outset Medical Amended and Restated 2010 Stock Incentive Plan (the "2010 Plan) and (Y) the Aggregate Cash Distribution is equal to or greater than $28.52 (reduced to $20.46 in 2020) as of the effective date of each Corporate Event. By: John L Brottem For: Martin Vazquez 2022-01-04